229 related articles for article (PubMed ID: 26126533)
21. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.
ElAli A; Hermann DM
Brain Pathol; 2012 Mar; 22(2):175-87. PubMed ID: 21767321
[TBL] [Abstract][Full Text] [Related]
22. Activation of liver X receptor decreases BACE1 expression and activity by reducing membrane cholesterol levels.
Cui W; Sun Y; Wang Z; Xu C; Xu L; Wang F; Chen Z; Peng Y; Li R
Neurochem Res; 2011 Oct; 36(10):1910-21. PubMed ID: 21630010
[TBL] [Abstract][Full Text] [Related]
23. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms.
Verschuren L; de Vries-van der Weij J; Zadelaar S; Kleemann R; Kooistra T
J Lipid Res; 2009 Feb; 50(2):301-11. PubMed ID: 18757914
[TBL] [Abstract][Full Text] [Related]
24. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS.
Speen AM; Kim HH; Bauer RN; Meyer M; Gowdy KM; Fessler MB; Duncan KE; Liu W; Porter NA; Jaspers I
J Biol Chem; 2016 Nov; 291(48):25192-25206. PubMed ID: 27703007
[TBL] [Abstract][Full Text] [Related]
25. 4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.
Bernotas RC; Singhaus RR; Kaufman DH; Travins JM; Ullrich JW; Unwalla R; Quinet E; Evans M; Nambi P; Olland A; Kauppi B; Wilhelmsson A; Goos-Nilsson A; Wrobel J
Bioorg Med Chem Lett; 2010 Jan; 20(1):209-12. PubMed ID: 19932617
[TBL] [Abstract][Full Text] [Related]
26. ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.
Di D; Wang Z; Liu Y; Luo G; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2012 Apr; 421(1):152-6. PubMed ID: 22516753
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo.
Escolà-Gil JC; Julve J; Llaverias G; Urpi-Sarda M; Silvennoinen R; Lee-Rueckert M; Andres-Lacueva C; Blanco-Vaca F
Transl Res; 2013 Feb; 161(2):110-7. PubMed ID: 23146569
[TBL] [Abstract][Full Text] [Related]
28. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
[TBL] [Abstract][Full Text] [Related]
29. Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.
van der Stoep M; Li Z; Calpe-Berdiel L; van der Sluis RJ; Saleh P; McKinnon HJ; Smit MJ; Korporaal SJ; Van Berkel TJ; Van Eck M; Hoekstra M
Biochem Pharmacol; 2013 Dec; 86(11):1594-602. PubMed ID: 24095721
[TBL] [Abstract][Full Text] [Related]
30. Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4.
Pascual-García M; Carbó JM; León T; Matalonga J; Out R; Van Berkel T; Sarrias MR; Lozano F; Celada A; Valledor AF
J Immunol; 2011 Apr; 186(8):4656-67. PubMed ID: 21398609
[TBL] [Abstract][Full Text] [Related]
31. The liver X receptor (LXR) and its target gene ABCA1 are regulated upon low oxygen in human trophoblast cells: a reason for alterations in preeclampsia?
Plösch T; Gellhaus A; van Straten EM; Wolf N; Huijkman NC; Schmidt M; Dunk CE; Kuipers F; Winterhager E
Placenta; 2010 Oct; 31(10):910-8. PubMed ID: 20709391
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression.
Ou X; Dai X; Long Z; Tang Y; Cao D; Hao X; Hu Y; Li X; Tang C
Sci China C Life Sci; 2008 May; 51(5):418-29. PubMed ID: 18785587
[TBL] [Abstract][Full Text] [Related]
33. Liver X receptor activation attenuates plaque formation and improves vasomotor function of the aortic artery in atherosclerotic ApoE(-/-) mice.
Chen J; Zhao L; Sun D; Narsinh K; Li C; Zhang Z; Qi S; Wei G; Li W; Guo W; Cao F
Inflamm Res; 2012 Dec; 61(12):1299-307. PubMed ID: 22833121
[TBL] [Abstract][Full Text] [Related]
34. VD
Munir MT; Ponce C; Santos JM; Sufian HB; Al-Harrasi A; Gollahon LS; Hussain F; Rahman SM
Mol Biol Rep; 2020 Oct; 47(10):7771-7782. PubMed ID: 32990902
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.
Cui HL; Grant A; Mukhamedova N; Pushkarsky T; Jennelle L; Dubrovsky L; Gaus K; Fitzgerald ML; Sviridov D; Bukrinsky M
J Lipid Res; 2012 Apr; 53(4):696-708. PubMed ID: 22262807
[TBL] [Abstract][Full Text] [Related]
36. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
Meng ZX; Yin Y; Lv JH; Sha M; Lin Y; Gao L; Zhu YX; Sun YJ; Han X
Diabetologia; 2012 Jun; 55(6):1733-44. PubMed ID: 22415588
[TBL] [Abstract][Full Text] [Related]
37. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu YL; Chen HY; Hu ML
J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
[TBL] [Abstract][Full Text] [Related]
38. Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: histological, gene set enrichment and expression analyses.
Sukardi H; Zhang X; Lui EY; Ung CY; Mathavan S; Gong Z; Lam SH
Biochim Biophys Acta; 2012 Jan; 1820(1):33-43. PubMed ID: 22047996
[TBL] [Abstract][Full Text] [Related]
39. Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury.
Crisafulli C; Di Paola R; Mazzon E; Paterniti I; Galuppo M; Genovese T; Bramanti P; Cappellani A; Cuzzocrea S
J Leukoc Biol; 2010 Feb; 87(2):309-21. PubMed ID: 20028773
[TBL] [Abstract][Full Text] [Related]
40. Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.
Baranowski M; Zabielski P; Błachnio-Zabielska AU; Harasim E; Chabowski A; Górski J
Cell Physiol Biochem; 2014; 33(4):1047-57. PubMed ID: 24732673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
